Project Grant R01EB037031

Award Date 4/5/25
Completion Date 3/31/29
Dollars Obligated $258K
Federal Grant Program
93.286
Assistance Type
Project Grant
Place of Performance
La Jolla, CA 92093, USA
Similar Awards
This $326,944 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering, under the CFDA 93.286 "Discovery and Applied Research for Technological Innovations to Improve Human Health" program, aims to develop a deployable and adaptable plasmonic sensing platform for cost-effective, sensitive, and accurate point-of-need infectious disease testing. The grant will fund the development of catalytic surface-enhanced Raman scattering (SERS) sensors based on...
This $1,200,000 Project Grant award from the National Science Foundation's (NSF) Computer and Information Science and Engineering (CISE) program (CFDA 47.070) supports the development of innovative sensing technologies that integrate DNA nanotechnology and CMOS electronics for next-generation diagnostics. The key objectives of this 4-year project are to: 1) develop molecular engineering techniques for in-situ signal amplification of aptamer biosensors using DNA origami nanotechnology; 2)...
This $1,165,298 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) aims to develop novel nanopore- and click-chemistry-based approaches for rapid, culture-independent detection of sepsis-causing pathogens directly from blood samples. The 5-year project, starting on July 1, 2024, will engineer nanopore biosensors and multiplex click chemistry assays capable of detecting sepsis-causing protein...
This $448,818 Project Grant awarded by the National Science Foundation (NSF) Engineering program (CFDA 47.041) aims to develop a miniaturized, sensitive, and user-friendly electromagnetic (EM) bacteria sensing platform covering RF-to-millimeter-wave frequencies. The project will integrate physics-based and biochemistry-based detection methods to rapidly and accurately identify bacterial infections without the need for cell culturing. Key innovations include: 1) Ultrasensitive biosensing...
The federal Project Grant award of $249,000 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health (CFDA 93.286) program, supports the development of a novel split enzyme diagnostic platform for rapid, sensitive detection of biomarkers at the point of care. The key objectives are to: Incorporate binding domains into a split adenylate cyclase system to detect clinically...
This Project Grant award for $447,304, provided by the National Institute of Biomedical Imaging and Bioengineering under the Discovery and Applied Research for Technological Innovations to Improve Human Health (CFDA 93.286) program, supports the development of a compact single-molecule assay (SIMOA) system that integrates electronics and microfluidics within a single integrated circuit (IC) chip. The project aims to create a CMOS-embedded microfluidic chip capable of electronically counting...
This $200,000 Project Grant award from the National Science Foundation (NSF) Engineering program (CFDA 47.041) aims to improve the stability and sensitivity of a heat-resistant CRISPR-Cas13 enzyme system for enhanced RNA detection capabilities. The University of Connecticut is the prime awardee, and the project involves: Investigating the structure and mechanism of the thermostable Cas13 enzyme to enable rational engineering. Producing new Cas13 variants with superior thermostability,...
The National Science Foundation (NSF), under its Engineering program (CFDA 47.041), awarded a $429,832 Project Grant to the University of Massachusetts (UMass) to develop a novel method for rapid and sensitive detection of nucleic acids such as DNA and RNA. The main objectives of the 5-year project are to: Determine the nanomechanoelectrical transduction principle of nucleic-acid nanostructures tethered to a graphene transistor and oscillating in an electric field. Achieve rapid,...
This $430,785 National Science Foundation (NSF) CAREER award to the Regents of the University of California at Riverside (UC Riverside), awarded under the NSF Engineering program (CFDA 47.041), is focused on developing novel CRISPR-based biosensing technologies for the ultra-accurate detection of disease-related single nucleotide polymorphisms (SNPs). The central goals of the 5-year project are to: 1) enable ultra-accurate SNP detection using a CRISPR-Cas14 biosensor, 2) design a ratiometric...
This $349,566 Project Grant award from the National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) supports the development of Biosensing Instrument Inc.'s Spotting-Free Nano-Oscillator Array (SFNOA) technology. The SFNOA system aims to provide high-throughput, label-free quantification of ligand binding kinetics to transmembrane proteins in their native states. Key innovations include the use...

This $257,807 federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (CFDA 93.286 "Discovery and Applied Research for Technological Innovations to Improve Human Health") will support the development of living biosensors for detecting and analyzing DNA at the single-base level, without requiring sample purification or specialized equipment. The proposed biosensors will use natural bacterial competence and CRISPR-Cas systems to pull DNA from raw samples, analyze it, and produce a detectable output signal using a lateral flow assay, similar to a home pregnancy or COVID-19 test. The biosensors will be designed to detect DNA sequences associated with urinary tract pathogens, E. coli, and antibiotic-resistant Salmonella, enabling rapid and equipment-free diagnostics at the point of care. This 4-year project, running from April 2025 to March 2029, aims to develop a hybrid living biosensor/lateral flow assay that requires minimal sample preparation and expertise, yet can achieve single-base DNA resolution for a range of clinical and environmental applications.

Generated 4/8/25, 3:51 AM